ProPhase Labs, Inc.

OTC:PRPH

Pharmaceutical Preparations·NEW YORK, NY

Prophase is the first stage of cell division in both mitosis and meiosis. Beginning after interphase, DNA has already been replicated when the cell enters prophase.

CEO

Karkus Ted William

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/19/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/20/25	→
10-K/A	FY 2024	12/31/24	4/30/25	→
10-K	FY 2024	12/31/24	4/1/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

Earnings Releases (8-K)

14 shown

Filed	Period
11/19/25	Q4 FY2025	→
8/13/25	Q3 FY2025	→
5/20/25	Q2 FY2025	→
3/31/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
↓

News (8-K)

66 shown

Filed	Type	Description
2/13/26	Other	Other Events	→
2/13/26	Other	Other Events	→
1/27/26	Other	Other Events	→
1/23/26	Other	Other Events	→
1/23/26	Agreement	Entry into a Material Definitive Agreement	→
1/9/26	Other	Other Events	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/29/25	424B5	424B5	→
12/19/25	424B5	424B5	→
10/21/25	S-1	S-1	→
10/15/25	424B5	424B5	→
10/8/25	424B3	424B3	→
10/6/25	424B3	424B3	→
↓

Filing History(913 filings)

TypeDateAccessionPeriodSize

8-K

Feb 13, 2026

0001493152-26-0067848-K

Feb 3, 2026

242.3 KB

8-K

Feb 13, 2026

0001493152-26-0067858-K

Feb 2, 2026

227.6 KB

8-K

Jan 27, 2026

0001493152-26-0037248-K

Jan 26, 2026

223.6 KB

8-K

Jan 23, 2026

0001493152-26-0034608-K

Jan 22, 2026

210.7 KB

8-K

Jan 23, 2026

0001493152-26-0034568-K

Jan 23, 2026

872.8 KB

25-NSE

Jan 23, 2026

0001354457-26-000084

—

3.7 KB

8-K

Jan 9, 2026

0001493152-26-0011438-K

Jan 9, 2026

232.5 KB

8-K

Jan 9, 2026

0001493152-26-0011348-K

Jan 9, 2026

195.7 KB

8-K

Jan 2, 2026

0001493152-26-0001758-K

Dec 29, 2025

280.7 KB

424B5

Dec 29, 2025

0001493152-25-029417424B5

—

1.0 MB

8-K

Dec 19, 2025

0001493152-25-0285378-K

Dec 19, 2025

240.9 KB

8-K

Dec 19, 2025

0001493152-25-0284838-K

Dec 12, 2025

283.4 KB

424B5

Dec 19, 2025

0001493152-25-028480424B5

—

987.4 KB

8-K/A

Dec 18, 2025

0001493152-25-0283178-K/A

Dec 10, 2025

5.4 MB

8-K/A

Dec 12, 2025

0001493152-25-0273998-K/A

Dec 10, 2025

5.4 MB

8-K

Dec 12, 2025

0001493152-25-0273178-K

Dec 10, 2025

203.8 KB

8-K

Nov 26, 2025

0001493152-25-0251028-K

Nov 24, 2025

205.9 KB

8-K

Nov 25, 2025

0001493152-25-0249888-K

Nov 21, 2025

204.5 KB

8-K

Nov 25, 2025

0001493152-25-0249868-K

Nov 19, 2025

199.2 KB

10-Q

Nov 19, 2025

0000868278-25-00001710-Q

Sep 30, 2025

9.4 MB

8-K

Nov 19, 2025

0001493152-25-0241748-K

Nov 19, 2025

377.3 KB

NT 10-Q

Nov 14, 2025

0001493152-25-023490NT 10-Q

Sep 30, 2025

43.6 KB

Nov 10, 2025

0001493152-25-0216023

Jun 20, 2025

3.2 KB

DEF 14A

Oct 31, 2025

0001493152-25-020375DEF 14A

Oct 31, 2025

1.2 MB

S-1

Oct 21, 2025

0001493152-25-018819S-1

—

747.8 KB

25 filings shown

ProPhase Labs, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(913 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
10/31/25	DEF 14A	DEF 14A	→
10/21/25	PRE 14A	PRE 14A	→
8/19/25	DEFA14A	DEFA14A	→
8/15/25	DEF 14A	DEF 14A	→
7/28/25	PRE 14A	PRE 14A	→
6/23/25	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
11/10/25	3	3	→
9/11/25	4	4	→
2/21/25	4	4	→
2/21/25	3	3	→
2/18/25	4	4	→
2/18/25	4	4	→
↓